Kevin Tong
Endocrinology, Diabetes & Metabolism · Lakewood, CONPI 1447356753
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 248 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,175 and has fallen 98.1% since, to $22 in 2022.
Across 248 payments — averaging $13.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amneal Pharmaceuticals LLC$605
- Mannkind Corporation$467
- AbbVie$377
- Lilly USA, LLC$367
- Boehringer Ingelheim$278
- Novo Nordisk$195
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,350100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amneal Pharmaceuticals LLC | 48 | $605 |
| Mannkind Corporation | 53 | $467 |
| AbbVie(2 entities) | 16 | $377 |
| Lilly USA, LLC | 27 | $367 |
| Boehringer Ingelheim | 21 | $278 |
| Novo Nordisk | 18 | $195 |
| Johnson & Johnson | 10 | $165 |
| Sanofi-aventis U.S. LLC | 10 | $132 |
| Amarin Pharma, Inc. | 8 | $130 |
| Merck | 6 | $85 |
| Bayer | 4 | $77 |
| AstraZeneca | 5 | $76 |
| Esperion Therapeutics, Inc. | 2 | $54 |
| Eisai Inc. | 3 | $49 |
| Insulet Corporation | 2 | $39 |
| Astellas Pharma US Inc | 2 | $38 |
| Seqirus USA Inc | 2 | $29 |
| Abbott | 1 | $24 |
| Amryt Pharma Holdings Ltd | 1 | $23 |
| Clarus Therapeutics Inc. | 1 | $23 |
| Amgen | 1 | $19 |
| Nalpropion Pharmaceuticals LLC | 1 | $17 |
| Radius Health, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Philips North America LLC | 1 | $13 |
| Aegerion Pharmaceuticals, Inc. | 1 | $11 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
How this compares
$3,350 in reported general payments places this provider in the 65th percentile of 120 endocrinology, diabetes & metabolism providers in Colorado.
See all endocrinology, diabetes & metabolism providers in Colorado →
Other endocrinology, diabetes & metabolism in Lakewood
- Jennifer BernardLakewood$1K
- Alexandra ReiherLakewood$1K
- Rachana ThapaLakewood$967
- Leigh PerreaultBoulder$1.7M
- Satish GargAurora$347K
- Viralkumar ShahAurora$256K
- Neda RasouliAurora$188K
- Michelle CassaraArvada$141K
- Halis AkturkAurora$109K
- Irinel StanciuArvada$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.